Literature DB >> 18428421

The Catalogue of Somatic Mutations in Cancer (COSMIC).

S A Forbes1, G Bhamra, S Bamford, E Dawson, C Kok, J Clements, A Menzies, J W Teague, P A Futreal, M R Stratton.   

Abstract

COSMIC is currently the most comprehensive global resource for information on somatic mutations in human cancer, combining curation of the scientific literature with tumor resequencing data from the Cancer Genome Project at the Sanger Institute, U.K. Almost 4800 genes and 250000 tumors have been examined, resulting in over 50000 mutations available for investigation. This information can be accessed in a number of ways, the most convenient being the Web-based system which allows detailed data mining, presenting the results in easily interpretable formats. This unit describes the graphical system in detail, elaborating an example walkthrough and the many ways that the resulting information can be thoroughly investigated by combining data, respecializing the query, or viewing the results in different ways. Alternate protocols overview the available precompiled data files available for download. Copyright 2008 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18428421      PMCID: PMC2705836          DOI: 10.1002/0471142905.hg1011s57

Source DB:  PubMed          Journal:  Curr Protoc Hum Genet        ISSN: 1934-8258


  10 in total

1.  Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

2.  Pten, a protean tumor suppressor.

Authors:  G L Mutter
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

3.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders.

Authors:  Ada Hamosh; Alan F Scott; Joanna Amberger; Carol Bocchini; David Valle; Victor A McKusick
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

4.  The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants.

Authors:  K Scheffzek; M R Ahmadian; W Kabsch; L Wiesmüller; A Lautwein; F Schmitz; A Wittinghofer
Journal:  Science       Date:  1997-07-18       Impact factor: 47.728

5.  Recurrent KRAS codon 146 mutations in human colorectal cancer.

Authors:  Sarah Edkins; Sarah O'Meara; Adrian Parker; Claire Stevens; Marcelo Reis; Siân Jones; Chris Greenman; Helen Davies; Gillian Dalgliesh; Simon Forbes; Chris Hunter; Raffaella Smith; Philip Stephens; Peter Goldstraw; Andrew Nicholson; Tsun Leung Chan; Victor E Velculescu; Siu Tsan Yuen; Suet Yi Leung; Michael R Stratton; P Andrew Futreal
Journal:  Cancer Biol Ther       Date:  2006-08-01       Impact factor: 4.742

Review 6.  Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.

Authors:  Gerd P Pfeifer; Mikhail F Denissenko; Magali Olivier; Natalia Tretyakova; Stephen S Hecht; Pierre Hainaut
Journal:  Oncogene       Date:  2002-10-21       Impact factor: 9.867

7.  Mutagenesis of the N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine DNA adduct in mammalian cells. Sequence context effects.

Authors:  S Shibutani; A Fernandes; N Suzuki; L Zhou; F Johnson; A P Grollman
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

8.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.

Authors:  Audrey Petitjean; Ewy Mathe; Shunsuke Kato; Chikashi Ishioka; Sean V Tavtigian; Pierre Hainaut; Magali Olivier
Journal:  Hum Mutat       Date:  2007-06       Impact factor: 4.878

9.  Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40.

Authors:  F Bergmann; S Aulmann; M N Wente; R Penzel; I Esposito; J Kleeff; H Friess; P Schirmacher
Journal:  J Clin Pathol       Date:  2006-02-23       Impact factor: 3.411

Review 10.  A census of human cancer genes.

Authors:  P Andrew Futreal; Lachlan Coin; Mhairi Marshall; Thomas Down; Timothy Hubbard; Richard Wooster; Nazneen Rahman; Michael R Stratton
Journal:  Nat Rev Cancer       Date:  2004-03       Impact factor: 60.716

  10 in total
  423 in total

1.  An overview of the c-MET signaling pathway.

Authors:  Shawna Leslie Organ; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

Review 2.  Molecular prescreening to select patient population in early clinical trials.

Authors:  Jordi Rodón; Cristina Saura; Rodrigo Dienstmann; Ana Vivancos; Santiago Ramón y Cajal; José Baselga; Josep Tabernero
Journal:  Nat Rev Clin Oncol       Date:  2012-04-03       Impact factor: 66.675

3.  Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation.

Authors:  Peng Zhang; Scott Becka; Sonya E L Craig; David T Lodowski; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Cell Commun Adhes       Date:  2009-12

4.  Germline BAP1 mutations and tumor susceptibility.

Authors:  Alisa M Goldstein
Journal:  Nat Genet       Date:  2011-09-28       Impact factor: 38.330

5.  The mutation spectrum revealed by paired genome sequences from a lung cancer patient.

Authors:  William Lee; Zhaoshi Jiang; Jinfeng Liu; Peter M Haverty; Yinghui Guan; Jeremy Stinson; Peng Yue; Yan Zhang; Krishna P Pant; Deepali Bhatt; Connie Ha; Stephanie Johnson; Michael I Kennemer; Sankar Mohan; Igor Nazarenko; Colin Watanabe; Andrew B Sparks; David S Shames; Robert Gentleman; Frederic J de Sauvage; Howard Stern; Ajay Pandita; Dennis G Ballinger; Radoje Drmanac; Zora Modrusan; Somasekar Seshagiri; Zemin Zhang
Journal:  Nature       Date:  2010-05-27       Impact factor: 49.962

Review 6.  Genetic studies in intellectual disability and related disorders.

Authors:  Lisenka E L M Vissers; Christian Gilissen; Joris A Veltman
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

Review 7.  NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells.

Authors:  Yu Jen Jan; Jie-Fu Chen; Yazhen Zhu; Yi-Tsung Lu; Szu Hao Chen; Howard Chung; Matthew Smalley; Yen-Wen Huang; Jiantong Dong; Li-Ching Chen; Hsiao-Hua Yu; James S Tomlinson; Shuang Hou; Vatche G Agopian; Edwin M Posadas; Hsian-Rong Tseng
Journal:  Adv Drug Deliv Rev       Date:  2018-03-15       Impact factor: 15.470

8.  Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test.

Authors:  Brennan Decker; Heidi G Parker; Deepika Dhawan; Erika M Kwon; Eric Karlins; Brian W Davis; José A Ramos-Vara; Patty L Bonney; Elizabeth A McNiel; Deborah W Knapp; Elaine A Ostrander
Journal:  Mol Cancer Res       Date:  2015-03-12       Impact factor: 5.852

9.  Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation.

Authors:  Kathryn E Hacker; Catherine C Fahey; Stephen A Shinsky; Yun-Chen J Chiang; Julia V DiFiore; Deepak Kumar Jha; Andy H Vo; Jordan A Shavit; Ian J Davis; Brian D Strahl; W Kimryn Rathmell
Journal:  J Biol Chem       Date:  2016-08-15       Impact factor: 5.157

10.  Clinical investigation of EGFR mutation detection by pyrosequencing in lung cancer patients.

Authors:  Hee Joung Kim; Seo Young Oh; Wan Seop Kim; Sun Jong Kim; Gwang Ha Yoo; Won Dong Kim; Kye Young Lee
Journal:  Oncol Lett       Date:  2012-10-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.